A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract ; volume:9 ; number:1 ; day:12 ; month:3 ; year:2016 ; pages:1-8 ; date:12.2016
BMC Research Notes / Biomed Central; 9, Heft 1 (12.3.2016), 1-8, 12.2016
- Urheber
-
Graham, J. S.
- Beteiligte Personen und Organisationen
-
Boyd, K.
Coxon, F. Y.
Wall, L. R.
Eatock, M. M.
Maughan, T. S.
Highley, M.
Soulis, E.
Harden, S.
Bützberger-Zimmerli, P.
Evans, T. R. J.
SpringerLink (Online service)
- DOI
-
10.1186/s13104-015-1778-4
- URN
-
urn:nbn:de:1111-2016031539455
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Graham, J. S.
- Boyd, K.
- Coxon, F. Y.
- Wall, L. R.
- Eatock, M. M.
- Maughan, T. S.
- Highley, M.
- Soulis, E.
- Harden, S.
- Bützberger-Zimmerli, P.
- Evans, T. R. J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer
Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
Eine randomisierte Phase-II-Studie mit Capecitabin, Oxaliplatin versus Gemcitabin, Capecitabin versus Gemcitabin, Oxaliplatin bei Patienten mit lokal fortgeschrittenem inoperablem oder metastasiertem Pankreaskarzinom
Eine randomisierte Phase-II-Studie mit Capecitabin, Oxaliplatin versus Gemcitabin, Capecitabin versus Gemcitabin, Oxaliplatin bei Patienten mit lokal fortgeschrittenem inoperablem oder metastasiertem Pankreaskarzinom
Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis
Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis
Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
Prolonged administration of the granisetron transdermal delivery system reduces capecitabine plus oxaliplatin regimen induced nausea and vomiting
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial
Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer
Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer
Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
Eine randomisierte Phase-II-Studie mit Capecitabin, Oxaliplatin versus Gemcitabin, Capecitabin versus Gemcitabin, Oxaliplatin bei Patienten mit lokal fortgeschrittenem inoperablem oder metastasiertem Pankreaskarzinom
Eine randomisierte Phase-II-Studie mit Capecitabin, Oxaliplatin versus Gemcitabin, Capecitabin versus Gemcitabin, Oxaliplatin bei Patienten mit lokal fortgeschrittenem inoperablem oder metastasiertem Pankreaskarzinom
Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis
Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis
Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
Prolonged administration of the granisetron transdermal delivery system reduces capecitabine plus oxaliplatin regimen induced nausea and vomiting
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial
Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer
Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer
Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
Eine randomisierte Phase-II-Studie mit Capecitabin, Oxaliplatin versus Gemcitabin, Capecitabin versus Gemcitabin, Oxaliplatin bei Patienten mit lokal fortgeschrittenem inoperablem oder metastasiertem Pankreaskarzinom
Eine randomisierte Phase-II-Studie mit Capecitabin, Oxaliplatin versus Gemcitabin, Capecitabin versus Gemcitabin, Oxaliplatin bei Patienten mit lokal fortgeschrittenem inoperablem oder metastasiertem Pankreaskarzinom
Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis
Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis
Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
Prolonged administration of the granisetron transdermal delivery system reduces capecitabine plus oxaliplatin regimen induced nausea and vomiting
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial